Assetmark »

Madrigal Pharmaceuticals shares owned by Assetmark

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Assetmark

Quarter filed Position value Share count Share price at filing
2024-09-30 $837k 3.9k 212.22
2024-06-30 $1.0M 3.6k 280.16

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Core S&p500 Etf (IVV)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Assetmark

Top funds holding Madrigal Pharmaceuticals

Henderson Group
Paulson & Co
Baker Bros. Advisors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
T. Rowe Price Associates
Susquehanna International
Jane Street
Geode Capital Management
Artisan Partners Limited Partnership
Rock Springs Capital Management
Erste Asset Management GmbH
Morgan Stanley

View all funds holding Madrigal Pharmaceuticals